Loading viewer...
earnings
Format: PDF earnings
Creo Medical Group plc presents FY2023 financial results and FY2024 outlook, highlighting total sales of £30.8m and 2.5x revenue increase from Speedboat Inject and CROMA products. The company achieved 49.6% gross margin and reduced underlying operating losses, with strong Q1-24 trading and growing consumables sales supporting continued growth plans.
earnings
14 Pages
SiriusPoint Ltd.
Sibanye Stillwater H1 2023 Operating & Financial Results Presentation
earningsearnings
68 Pages
Sibanye Stillwater Limited
Westlake Corporation Q2 2022 Earnings Presentation
earningsearnings
17 Pages
Westlake Corporation